Checkpoint proteins are an integral part of the immune system and are used by the tumor
cells to evade immune response, which helps them grow uncontrollably. By blocking these …

Background: The albumin levels may potentially be used as a prognostic biomarker in
patients with cancertreated with immune checkpoint inhibitors (ICIs) due to its close …

Objective Considering the striking evidence revealed by immunotherapy in advanced or
metastatic bladder cancer, investigators have explored neoadjuvant immunotherapy and …

Pembrolizumab is the standard for the first and second lines in treating metastatic urothelial
carcinoma (UC). This systematic review and meta-analysis aimed to assess the value of …

Background Enfortumab vedotin (EV) is an antibody‐drug conjugate showing significant
overall survival (OS) benefit versus chemotherapy for patients with previously treated locally …

Purpose To analyze and summarize the efficacy of immune checkpoint inhibitor (ICI) alone
or in combination therapy for renal cell carcinoma (RCC) and urothelial carcinoma (UC) …

Background Recently, immune checkpoint inhibitor (ICI)-combination therapies have
radically altered the treatment landscape in metastatic renal cell carcinoma (mRCC). No …

Context Platinum-based combination chemotherapy is the standard treatment for advanced
or metastatic urothelial carcinoma (AMUC). However, data comparing the efficacy of different …

Simple Summary Despite immune checkpoint inhibitors'(ICIs) improved overall survival in
urothelial carcinoma patients, only a minority of them benefit from immunotherapy …

Urothelial carcinoma (UC) occupies a high incidence among all the genitourinary
malignancies. Immune checkpoint inhibitors (ICIs), as alternative treatments of metastatic …